We are live on ! Find out more
ELC

Edgar Lomax Company Portfolio holdings

AUM $1.4B
1-Year Est. Return 20.67%
This Fund
S&P 500
This Quarter Est. Return
-7.2%
1 Year Est. Return
+20.67%
3 Year Est. Return
+56.64%
5 Year Est. Return
+81.49%
10 Year Est. Return
+226.33%
AUM
$1.45B
AUM Growth
-$150M
Cap. Flow
-$19.9M
Cap. Flow %
-1.37%
Top 10 Hldgs %
43.28%
Holding
59
New
1
Increased
1
Reduced
53
Closed
–

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$16.4M
2
PFE icon
Pfizer
PFE
+$16M

Top Sells

Rank Stock Value
1
MET icon
MetLife
MET
+$15.2M
2
COF icon
Capital One
COF
+$13.4M
3
INTC icon
Intel
INTC
+$8.54M
4
CVX icon
Chevron
CVX
+$1.21M
5
XOM icon
ExxonMobil
XOM
+$1.02M

Sector Composition

Rank Sector Weight
1 Healthcare 27.61%
2 Financials 17.58%
3 Industrials 10.97%
4 Consumer Staples 10.3%
5 Energy 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BAC icon
26
Bank of America
BAC
$441B
$19.5M 1.35%
644,455
-7,015
-1% -$235K
BNY
27
Bank of New York Mellon
BNY
$108B
$19M 1.31%
493,309
-5,425
-1% -$231K
COP icon
28
ConocoPhillips
COP
$142B
$18.9M 1.3%
184,350
-3,420
-2% -$341K
RTX icon
29
RTX Corp
RTX
$301B
$18.5M 1.28%
226,330
-1,350
-0.6% -$122K
DUK icon
30
Duke Energy
DUK
$96.6B
$18.3M 1.26%
196,406
-2,340
-1% -$251K
CSCO icon
31
Cisco
CSCO
$476B
$18.1M 1.25%
452,243
-4,960
-1% -$220K
TGT icon
32
Target
TGT
$66.8B
$16.9M 1.17%
114,209
-1,345
-1% -$215K
TXN icon
33
Texas Instruments
TXN
$254B
$16.3M 1.13%
105,295
-1,070
-1% -$179K
MDLZ icon
34
Mondelez International
MDLZ
$80.1B
$15.8M 1.09%
288,400
-1,750
-0.6% -$109K
EMR icon
35
Emerson Electric
EMR
$87.5B
$15.7M 1.08%
213,741
-2,305
-1% -$191K
MDT icon
36
Medtronic
MDT
$110B
$15.5M 1.07%
191,950
-2,155
-1% -$194K
UNP icon
37
Union Pacific
UNP
$175B
$15.3M 1.06%
78,725
-815
-1% -$180K
PG icon
38
Procter & Gamble
PG
$342B
$14.6M 1.01%
+115,510
New +$16.4M
GILD icon
39
Gilead Sciences
GILD
$162B
$13.8M 0.95%
223,790
-2,545
-1% -$160K
WFC icon
40
Wells Fargo
WFC
$265B
$13M 0.9%
322,025
-3,605
-1% -$155K
LOW icon
41
Lowe's Companies
LOW
$122B
$11.2M 0.77%
59,615
-705
-1% -$137K
BMY icon
42
Bristol-Myers Squibb
BMY
$131B
$11M 0.76%
154,360
-1,600
-1% -$116K
LMT icon
43
Lockheed Martin
LMT
$135B
$10.3M 0.71%
26,685
-140
-0.5% -$58.5K
ABBV icon
44
AbbVie
ABBV
$431B
$9.37M 0.65%
69,848
-400
-0.6% -$57.4K
PEP icon
45
PepsiCo
PEP
$189B
$8.71M 0.6%
53,370
-540
-1% -$93.1K
USB icon
46
US Bancorp
USB
$99.4B
$6.91M 0.48%
171,306
-1,910
-1% -$88.4K
C icon
47
Citigroup
C
$224B
$6.64M 0.46%
159,455
-1,835
-1% -$90.7K
AVGO icon
48
Broadcom
AVGO
$2T
$6.42M 0.44%
144,600
-2,000
-1% -$102K
JPM icon
49
JPMorgan Chase
JPM
$947B
$6.36M 0.44%
60,845
-605
-1% -$69.4K
T icon
50
AT&T
T
$162B
$5.99M 0.41%
390,742
-4,280
-1% -$77.9K
1
2
3

Similar funds

FCP
Fidelis Capital Partners Tampa, Florida $1.4B AUM 31.16% 1-Year Est. Return
TWM
Tradition Wealth Management Edina, Minnesota $1.41B AUM 19.71% 1-Year Est. Return
AI
Atom Investors Austin, Texas $1.4B AUM 23.77% 1-Year Est. Return
IAS
Insigneo Advisory Services Miami, Florida $1.41B AUM 27.46% 1-Year Est. Return
EA
Efficient Advisors Mason, Ohio $1.41B AUM 13.81% 1-Year Est. Return
QC
Quent Capital New York $1.41B AUM 22.9% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
SP
Steelhead Partners Seattle, Washington $1.39B AUM 0.01% 1-Year Est. Return

Edgar Lomax Company's Q3 2022 Portfolio in Review

As of Q3 2022, Edgar Lomax Company held 59 positions worth $1.45B, down 9.4% from $1.6B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 1.7%. Edgar Lomax Company opened 1 new position and made no exits, leaving the 59-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Financials and Industrials.

  • Edgar Lomax Company's largest Q3 2022 buy was Procter & Gamble: 115,510 shares worth $14.6M.
  • Edgar Lomax Company added most to Pfizer in Q3 2022, an estimated $16M increase.
  • Edgar Lomax Company's biggest Q3 2022 reduction was MetLife, cutting an estimated $15.2M.
  • Edgar Lomax Company's ten largest holdings make up 43% of its $1.45B portfolio in Q3 2022.
  • Edgar Lomax Company opened 1 new position and closed 0 in Q3 2022.
  • Edgar Lomax Company's portfolio value fell 9.4% quarter-over-quarter to $1.45B.

Based on Edgar Lomax Company's 13F filing for Q3 2022, filed 14 Nov 2022.